viral
ribonucleoprotein
complex
significantli
impact
replic
transcript
viral
rna
genom
although
np
regard
promis
antivir
druggabl
target
chemic
ligand
report
interact
ebov
np
marv
np
identifi
two
compound
tradit
chines
medicin
gancao
licoric
root
bind
np
combin
affin
mass
spectrometri
metabolom
approach
two
ligand
acid
licochalcon
verifi
defin
compound
mixtur
screen
character
individu
ligand
bind
assay
accompani
biophys
analys
demonstr
bind
acid
ebov
np
significantli
reduc
protein
thermal
stabil
induc
format
larg
np
oligom
disrupt
critic
associ
viral
ssrna
np
complex
wherea
compound
show
activ
marv
np
studi
reveal
substanti
potenti
new
analyt
techniqu
ligand
discoveri
natur
herb
resourc
addit
identif
chemic
ligand
influenc
oligomer
state
rnabind
function
ebov
np
shed
new
light
antivir
drug
develop
marburg
virus
marv
caus
sever
hemorrhag
fever
case
fatal
rate
approach
outbreak
undoubtedli
signific
threat
global
human
health
recent
largest
filoviru
epidem
western
africa
caus
ebov
makona
variant
import
ebov
nonafrican
countri
highlight
public
health
impact
pathogen
ebov
singlestrand
rna
ssrna
genom
transcrib
upon
viru
entri
host
cytosol
gener
least
eight
distinct
viral
protein
viral
genom
replic
mrna
transcript
carri
viral
rnadepend
rna
polymeras
complex
rdrp
complex
consist
viral
polymeras
l
viral
nucleoprotein
np
along
polymeras
cofactor
member
filoviru
famili
singlestrand
viral
genom
rna
encapsid
np
viral
genom
protect
recognit
cellular
innat
immun
system
degrad
ribonucleas
promin
role
viru
np
valid
target
antivir
drug
develop
manifest
studi
influenza
viru
iav
np
two
compound
nucleozin
found
target
iav
np
alter
oligomer
state
show
potent
antivir
activ
iav
infect
vitro
vivo
howev
chemic
ligand
report
toward
ebov
np
marv
np
known
ligand
ebov
np
peptid
deriv
protein
compon
within
viral
nucleocapsid
peptid
bind
np
high
affin
specif
inhibit
np
oligomer
releas
rna
nprna
complex
vitro
previou
eleg
structur
work
peptid
bound
ebov
np
complex
reveal
peptid
ligand
occlud
larg
surfac
area
import
np
assembl
nprna
interact
viral
rna
synthesi
result
strongli
impli
ebov
np
also
good
target
therapeut
develop
affin
mass
spectrometri
ms
emerg
versatil
complementari
approach
ligand
screen
drug
target
play
increasingli
vital
role
earli
drug
discoveri
import
advantag
msbase
ligand
discoveri
biophys
techniqu
biomolecualr
interact
analysi
lie
abil
detect
specif
ligand
complex
compound
mixtur
combinatori
librari
establish
affin
msbase
workflow
identif
affin
measur
chemic
ligand
toward
sever
antivir
protein
target
comparison
synthet
compound
mixtur
screen
potenti
affin
ms
wide
explor
ligand
screen
natur
product
extract
due
structur
complex
abund
variat
differ
constitu
work
combin
affin
ms
metabolom
approach
identif
chemic
ligand
ebov
np
marv
np
crude
extract
renown
tradit
chines
medicin
tcm
gancao
licoric
root
gancao
dri
root
glycyrrhiza
uralensi
fisch
licoric
g
inflata
bat
g
glabra
l
shown
wide
varieti
therapeut
properti
antivir
antihepatotox
antiinflammatori
antileukemogen
anticarcinogen
effect
clinic
treatment
liver
diseas
two
compound
discov
chines
licoric
bind
ebov
np
marv
np
verifi
defin
compound
mixtur
screen
character
individu
ligand
bind
assay
accompani
biophys
analys
demonstr
bind
one
ligand
ebov
np
significantli
reduc
protein
thermal
stabil
induc
format
larg
np
oligom
disrupt
critic
associ
viral
ssrna
np
complex
studi
reveal
substanti
potenti
affin
ms
coupl
metabolom
techniqu
ligand
discoveri
natur
herb
resourc
develop
smallmolecul
therapi
comprehens
screen
crude
extract
chines
licoric
viru
np
ligand
discoveri
devis
workflow
combin
affin
mass
spectrometri
metabolom
approach
fig
recombin
core
domain
ebola
viru
np
ebov
np
amino
acid
marburg
viru
np
marv
np
amino
acid
purifi
separ
incub
chines
licoric
extract
ultrafiltr
perform
isol
ligandbound
np
complex
compound
mixtur
dissoci
np
complex
proteinfre
control
subject
metabolom
analysi
use
liquid
chromatographi
coupl
highresolut
mass
spectrometri
lchrm
full
dataset
supplement
tabl
multivari
model
base
orthogon
partial
leastsquar
discrimin
analysi
oplsda
creat
differenti
compound
profil
crude
extract
protein
incub
sampl
control
sampl
type
np
experi
distinct
separ
three
sampl
group
indic
composit
compound
associ
np
complex
substanti
deviat
crude
extract
control
fig
appli
multipl
criteria
select
put
ligand
specif
enrich
ebov
np
marv
np
complex
includ
variabl
influenc
project
vip
score
repres
compound
implic
differ
np
complex
control
averag
sn
valu
rsd
indic
signific
chang
peak
intens
compound
protein
complex
rel
control
match
accur
mass
put
ligand
tcm
compound
databas
chines
licoric
see
detail
experiment
use
set
stringent
criteria
identifi
compon
licoric
extract
candid
ligand
bound
ebov
np
marv
np
respect
fig
tabl
although
put
structur
assign
compound
interest
base
hrm
msm
analysi
unambigu
structur
elucid
requir
strict
confirm
refer
standard
end
obtain
pure
standard
known
licoric
constitu
commerci
sourc
purif
licoric
extract
compound
list
supplement
figur
identif
compound
np
incub
sampl
control
base
match
retent
time
min
shift
accur
mass
da
deviat
refer
mean
eleven
featur
correspond
licoric
constitu
contain
two
pair
isom
identifi
color
code
vip
sn
plot
includ
reproduc
detect
featur
match
chines
licoric
compound
databas
fig
among
identifi
licoric
constitu
found
glycyrrhetin
acid
licochalcon
met
aforement
threshold
ebov
np
marv
np
ligand
red
symbol
fig
noteworthi
glycyrrhetin
acid
glycyrrhetin
acid
pair
diastereoisom
differ
c
h
tran
cisconfigur
coelut
lc
condit
studi
highresolut
ms
msm
spectra
acquir
protein
incub
sampl
support
structur
elucid
fig
addit
nmr
analysi
correspond
lc
fraction
put
ligand
reveal
glycyrrhetin
acid
domin
isom
licoric
extract
supplement
figur
valid
ligand
bind
np
use
pure
standard
verifi
bind
ligand
discov
licoric
extract
evalu
known
licoric
constitu
incub
ebov
np
marv
np
protein
mixtur
fourteen
pure
standard
equal
amount
affin
ms
analysi
figur
show
lchrm
chromatogram
protein
incub
sampl
control
two
type
np
experi
compound
averag
sn
ratio
rsd
indic
signific
increas
abund
protein
complex
thu
consid
ligand
np
target
compound
mixtur
highli
enrich
ebov
np
marv
np
complex
wherea
none
licoric
constitu
show
signific
bind
fig
character
ligand
bind
properti
incub
np
protein
separ
prior
affin
ms
analysi
use
previous
develop
method
sn
ratio
bind
fraction
equilibrium
dissoci
constant
k
obtain
individu
compound
tabl
interestingli
two
diostereoisom
posit
binder
ebov
np
marv
np
medium
affin
also
verifi
ligand
np
yet
weak
affin
mm
tabl
addit
affin
ms
assay
perform
convent
spr
experi
verifi
bind
np
target
accord
affin
ms
result
sever
test
licoric
compon
also
show
neg
spr
respons
supplement
tabl
taken
togeth
bind
assay
compound
mixtur
pure
compound
affin
ms
spr
concordantli
valid
ligand
ebov
np
marv
np
consist
find
crude
extract
analysi
follow
valid
assay
suggest
integr
affin
ms
metabolom
workflow
highli
effect
discoveri
new
ligand
complex
tcm
extract
grey
symbol
repres
featur
detect
four
independ
replic
rsd
sn
ratio
across
replic
featur
also
match
accur
mass
chines
licoric
compound
databas
red
symbol
annot
two
put
ligand
bound
np
blue
symbol
annot
rest
constitu
chines
licoric
bind
np
colorcod
compound
identifi
hrm
msm
analysi
accord
refer
standard
bind
reduc
ebov
np
thermal
stabil
promot
np
oligomer
microscal
fluoresc
thermal
shift
assay
conduct
assess
np
thermal
stabil
upon
differ
ligand
bind
tabl
strikingli
larg
reduc
ebov
np
thermal
stabil
caus
decreas
protein
melt
temperatur
best
knowledg
first
report
compound
induc
substanti
instabl
viral
np
strongli
suggest
consider
conform
chang
ebov
np
upon
bind
margin
affect
ebov
np
thermal
stabil
test
licoric
tabl
bind
properti
specif
compound
np
measur
affin
ms
sd
shown
measur
independ
experi
triplic
ratio
peak
intens
protein
incub
sampl
vs
control
b
fraction
compound
associ
np
protein
complex
c
bind
compound
sn
constitu
effect
contrast
test
compound
includ
littl
influenc
marv
np
thermal
stabil
tabl
suggest
specif
impair
ebov
np
stabil
oligomer
state
viral
np
close
relat
function
replic
transcript
viral
rna
genom
ntermin
truncat
construct
ebov
np
residu
use
studi
entail
fold
core
domain
stay
rnafre
monomer
form
solut
howev
addit
ebov
np
solut
shift
monom
much
larger
molecular
weight
speci
shown
sizeexclus
chromatographi
inlin
multiangl
light
scatter
secmal
tabl
increas
molar
excess
eventu
produc
superlarg
complex
ebov
np
ligandbound
ebov
np
core
region
gave
rise
monodispers
peak
elut
void
volum
sec
close
resembl
peak
anoth
construct
well
character
form
larg
homooligomer
complex
supplement
figur
result
indic
shift
equilibrium
ebov
np
toward
nativ
oligomer
state
np
notabl
addit
structur
enantiom
convert
small
portion
monomer
ebov
np
oligom
contrast
anoth
licoric
constitu
littl
effect
mediat
oligomer
ebov
np
tabl
marv
np
truncat
construct
residu
use
studi
form
mix
popul
monom
tetram
larg
oligom
solut
interestingli
bind
marv
np
disrupt
tetram
conform
increas
fraction
monom
dosedepend
way
tabl
contrari
incub
marv
np
larg
promot
tetram
format
increas
wherea
reduc
fraction
monom
induc
signific
chang
monom
oligom
distribut
marv
np
tabl
taken
togeth
among
compound
investig
studi
display
profound
impact
thermal
stabil
oligomer
ebov
np
encourag
us
character
bind
mode
vitro
bioactiv
new
ligand
target
rnabind
groov
ebola
viru
np
crystal
structur
ebov
np
pdb
code
solv
previou
studi
featur
two
identifi
lobe
nlobe
span
np
residu
clobe
connect
togeth
flexibl
hing
locat
within
clobe
structur
highli
posit
charg
groov
locat
interfac
nand
clobe
constitut
potenti
rnabind
pocket
fig
pocket
major
positivecharg
crevic
involv
residu
adjac
minor
positivecharg
region
consist
residu
key
basic
residu
highli
conserv
across
ebola
viru
genu
whole
filoviru
famili
well
fig
report
play
essenti
role
viral
rna
encapsid
ebov
prolifer
host
cell
base
apo
protein
structur
employ
silico
dock
analysi
creat
potenti
model
bind
ebov
np
predict
ligand
bind
site
involv
residu
possibl
make
hydrogen
bond
ligand
fig
prepar
ebov
np
mutant
harbor
alanin
substitut
examin
ligand
bind
capac
use
affin
ms
approach
compar
wildtyp
protein
mutat
result
nearli
loss
bind
mutat
reduc
bind
effici
two
ligand
less
extent
fig
importantli
predict
bind
free
energi
kcalmol
much
lower
kcalmol
provid
molecular
basi
select
bind
one
diostereoisom
protein
target
furthermor
wherea
bind
strongli
induc
oligomer
wildtyp
ebov
np
less
obviou
shift
oligomer
state
ligand
observ
mutant
fig
c
result
suggest
two
new
ligand
discov
studi
interact
rnabind
groov
ebov
np
specif
residu
predict
dock
model
engag
np
oligomer
evalu
effect
ligand
mediat
ebov
np
interact
viral
ssrna
gener
anoth
construct
residu
order
purifi
rnafre
oligomer
ebov
np
bacteri
rna
copurifi
protein
remov
collect
monom
fraction
elut
sec
use
highsalt
buffer
nacl
supplement
figur
subsequ
dilut
lowsalt
condit
mm
nacl
trigger
spontan
np
oligomer
confirm
sec
analysi
supplement
figur
result
oligomer
rnafre
ebov
np
readili
bind
nucleotid
ssrna
low
micromolar
affin
measur
fluoresc
anisotropi
fig
next
competit
bind
assay
conduct
first
incub
monom
ebov
np
variou
concentr
dilut
mixtur
ad
rna
probe
incub
np
monom
caus
protein
oligomer
importantli
ligand
bound
np
oligom
found
compet
ssrna
interact
np
complex
increas
concentr
incub
result
proport
loss
ssrna
rnanp
complex
yield
half
maxim
inhibitori
concentr
ic
fig
result
indic
new
ligand
disrupt
interact
ebov
np
viral
ssrna
either
directli
occlud
rnabind
cleft
induc
conform
chang
np
oligom
would
impair
ssrna
associ
studi
report
two
novel
chemic
ligand
target
ebola
viru
marburg
viru
np
identifi
chines
licoric
combin
affin
ms
metabolom
techniqu
tradit
ultrafiltrationhplc
employ
ligand
discoveri
natur
product
medicin
plant
extract
previou
studi
use
hplc
coupl
uvvi
detector
search
compound
enrich
protein
incub
natur
product
extract
appli
mass
spectrometri
analysi
structur
identif
potenti
ligand
howev
limit
sensit
uvvi
detector
substanti
lower
chanc
captur
medium
low
abund
speci
complex
crude
extract
comparison
dozen
peak
typic
observ
ultrafiltrationhplc
chromatogram
hrmsbase
metabolom
experi
facilit
structur
identif
put
ligand
use
avail
refer
compound
structur
two
ligand
unambigu
determin
glycyrrhetin
acid
licochalcon
repres
first
chemic
ligand
report
partak
interact
filoviru
np
accompani
biophys
analys
demonstr
bind
impair
thermal
stabil
ebov
np
core
domain
trigger
protein
oligomer
disrupt
viral
rna
associ
oligomer
np
complex
prior
studi
document
ligand
ebov
np
peptid
deriv
ebov
protein
compon
viral
rnadepend
rna
polymeras
complex
rdrp
notabl
ntermin
peptid
maintain
np
nonoligomer
rnafre
state
np
yet
support
viral
rna
synthesi
tran
thu
previou
work
peptid
chaperon
np
assembl
grant
model
ebola
peptid
bind
np
prevent
np
associ
noncogn
rna
ie
cellular
nongenom
viral
rna
furthermor
specul
facilit
transfer
monomer
templatefre
np
viral
templat
rna
initi
rna
synthesi
contrast
chemic
ligand
discov
studi
exert
effect
opposit
peptid
induc
format
larg
oligomer
complex
np
core
domain
fig
tabl
result
remind
us
nucleozin
chemic
compound
target
influenza
np
induc
format
np
aggreg
antagon
nuclear
accumul
lead
cessat
viral
replic
vitro
anoth
chemic
disrupt
viral
rnainduc
oligomer
influenza
np
also
show
potent
antivir
activ
mani
differ
subtyp
influenza
viru
vitro
vivo
howev
compound
capabl
influenc
np
oligomer
state
discov
toward
ebola
viru
date
np
protein
integr
part
viral
nucleocapsid
intim
associ
viral
rna
templat
oligomer
state
particularli
import
maintain
templat
integr
provid
templat
access
viral
rdrp
abil
disrupt
ssrna
associ
np
complex
indic
ligand
upon
bind
rnafre
np
monom
may
induc
signific
conform
chang
result
oligom
longer
interact
viral
ssrna
effect
nativ
np
oligom
therefor
whether
deriv
pharmacolog
activ
ebola
viru
life
cycl
would
intrigu
question
address
futur
accord
silico
dock
result
predict
interact
rnabind
groov
ebov
np
compos
certain
basic
residu
particular
possibl
make
hydrogen
bond
hydroxyl
group
two
ligand
fig
substitut
alanin
result
signific
loss
bind
capac
residu
engag
np
oligomer
fig
also
notic
substitut
either
complet
abrog
bind
capac
suggest
may
residu
engag
ligand
interact
importantli
residu
compris
site
well
conserv
across
whole
filoviru
famili
fig
known
play
essenti
role
encapsid
viral
genom
ebov
prolifer
shed
light
antivir
drug
develop
consid
strong
homolog
core
domain
ebov
np
marv
np
would
specul
might
interact
rnabind
groov
marv
np
similar
fashion
noteworthi
exhibit
much
less
influenc
thermal
stabil
oligomer
state
marv
np
compar
ebov
np
probabl
protein
purifi
mix
form
monom
tetram
oligom
tabl
addit
lack
protein
structur
data
marv
np
render
difficult
predict
ligand
bind
mode
therefor
structur
biochem
studi
npligand
complex
need
definit
identifi
precis
interact
mode
glycyrrhetin
acid
fact
biotransform
metabolit
glycyrrhizin
intestin
flora
human
bodi
glycyrrhizin
wellcharacter
major
compon
chines
licoric
possess
wide
rang
pharmacolog
biolog
activ
glycyrrhizin
line
glycyrrhetin
acid
develop
china
japan
antiinflammatori
antivir
antiallerg
drug
liver
diseas
treatment
particular
notion
glycyrrhizin
report
inhibit
replic
sarsassoci
coranoviru
hepat
c
viru
furthermor
glycyrrhizin
exert
antivir
effect
influenza
virusinfect
cell
inhibit
viru
replic
proinflammatori
gene
express
interestingli
although
glycyrrhizin
ie
abund
constitu
chines
licoric
observ
direct
bind
ebov
np
marv
np
crude
extract
compound
mixtur
screen
fig
show
influenc
np
thermal
stabil
tabl
result
clearli
indic
primari
metabolit
glycyrrhizin
target
viral
np
directli
exhibit
multipl
biolog
activ
ebov
np
find
would
shed
new
light
understand
antivir
mechan
chines
licoric
given
structur
divers
novelti
numer
compound
natur
product
tradit
chines
medicin
studi
present
promis
new
approach
mine
great
resourc
natur
herb
ligand
discoveri
toward
therapeut
target
thu
aid
potenti
drug
develop
materi
reagent
ammonium
acet
formic
acid
tri
nacl
purchas
sigmaaldrich
st
loui
mo
usa
pepton
yeast
powder
iptg
ampicillin
imidazol
purchas
sangon
biotech
shanghai
co
ltd
shanghai
china
methyl
alcohol
acetonitril
hplcgrade
purchas
merck
darmstadt
germani
ultrapur
water
purifi
milliq
system
millipor
usa
centrifug
ultrafiltr
unit
kda
purchas
sartoriu
germani
protein
thermal
shift
dye
kit
tm
purchas
thermo
fisher
scientif
massachusett
usa
fourteen
standard
known
licoric
constitu
list
supplement
figur
purchas
chengdu
herbpurifi
co
ltd
chengdu
china
nation
institut
food
drug
control
beij
china
isol
use
report
protocol
protein
express
purif
clone
purif
perform
describ
previous
brief
gene
ebov
np
residu
clone
express
vector
gene
marv
np
residu
clone
express
vector
novogen
china
np
protein
carri
tag
fuse
c
terminu
e
coli
strain
biom
china
transform
express
vector
induc
isopropyl
iptg
optic
densiti
nm
follow
overnight
express
bacteri
cultur
harvest
lyse
buffer
mm
trishcl
ph
mm
nacl
use
ultrahigh
pressur
cell
disrupt
jnbio
china
clear
lysat
appli
ninta
column
elut
lysi
buffer
contain
imidazol
protein
subsequ
purifi
column
ge
healthcar
void
volum
ml
purifi
ebov
np
marv
np
pure
accord
sdspage
analysi
prepar
chines
licoric
extract
licoric
powder
g
macer
ml
vv
methanol
aqueou
solut
extract
ultrason
h
extract
solut
filter
concentr
dryness
use
combin
rotari
evapor
reduc
pressur
lyophil
result
powder
licoric
extract
store
readi
use
extract
powder
complet
dissolv
dmso
make
stock
solut
mgml
stock
dilut
ebov
np
incub
buffer
mm
trishcl
mm
nacl
mm
dtt
ph
marv
np
incub
buffer
mm
hepe
mm
nacl
ph
concentr
mgml
np
protein
mix
dilut
licoric
extract
solut
vv
final
volum
l
incub
kept
min
protein
incub
solut
filter
ultrafiltr
unit
kda
centrifug
g
min
retain
solut
membran
wash
twice
mm
ammonium
acet
result
solut
protein
complex
transfer
new
centrifug
tube
bound
compound
dissoci
methanol
deioniz
water
centrifug
compound
supernat
obtain
evapor
speed
vacuum
reconstitut
methanol
analyz
liquid
chromatographi
coupl
highresolut
mass
spectrometri
lchrm
proteinfre
control
prepar
use
buffer
substitut
np
incub
sampl
prepar
four
replic
analyz
separ
compound
mixtur
analyz
water
synapt
highdefinit
mass
spectromet
milford
equip
water
acquiti
ultraperform
liquid
chromatographi
uplc
system
uplc
separ
carri
thermo
hypersil
gold
column
mm
mm
flow
rate
lmin
mobil
phase
formic
acid
formic
acid
b
lc
method
follow
min
b
min
b
min
b
min
b
kept
min
reequilibr
min
esi
ion
sourc
oper
neg
ion
mode
mass
spectra
acquir
within
mass
rang
mz
capillari
voltag
kv
sampl
cone
voltag
v
extract
cone
voltag
v
desolv
temperatur
sourc
temperatur
desolv
ga
flow
lh
intern
calibr
leucineenkephalin
le
infus
via
lockspray
interfac
achiev
mass
accuraci
within
ppm
dilut
sampl
crude
extract
stock
meoh
mgml
inject
everi
run
ensur
stabil
analyt
platform
msm
spectra
acquir
select
compound
precursor
collis
energi
set
ev
ion
sourc
condit
ident
ms
full
scan
data
process
np
ligand
identif
raw
lchrm
data
process
xcm
softwar
peak
align
peak
intens
ie
peak
area
determin
extract
ion
chromatogram
eic
check
review
consist
integr
across
sampl
analyz
peak
shape
exclud
background
nois
featur
np
incub
sampl
show
intens
loq
level
compound
lchrm
system
across
four
replic
kept
multivari
analysi
preprocess
data
set
use
input
simca
umetr
sweden
data
analysi
preced
supervis
orthogon
project
latent
structuresdiscrimin
analysi
oplsda
model
data
log
transform
pareto
scale
minim
heteroscedast
adjust
fold
differ
compon
model
valid
verifi
use
permut
test
cvanova
simca
also
check
good
fit
r
x
r
q
ebov
np
model
r
x
r
q
marv
np
model
contribut
compon
sampl
group
separ
reflect
variabl
influenc
project
vip
score
oplsda
also
calcul
ratio
peak
intens
protein
incub
sampl
vs
control
sn
compon
compon
match
accur
mass
tcm
compound
databas
chines
licoric
within
mda
mass
toler
show
sn
ratio
rsd
four
replic
recogn
put
licoric
constitu
data
use
make
vip
sn
plot
fig
potenti
np
ligand
licoric
extract
select
base
vip
score
averag
sn
ratio
rsd
tcm
compound
databas
purchas
neotrid
compani
beij
china
affin
ms
analysi
np
incub
pure
compound
licoric
compound
mixtur
screen
commerci
avail
standard
mix
final
concentr
compound
incub
either
np
protein
individu
compound
bind
assay
two
standard
glycyrrhetin
acid
licochalcon
separ
incub
either
np
keep
protein
compound
incub
sampl
total
volum
l
prepar
correspond
np
buffer
describ
earlier
maintain
min
ultrafiltr
complex
dissoci
conduct
result
compound
mixtur
specif
ligand
analyz
lchrm
use
instrument
describ
earlier
lc
method
licoric
extract
analysi
also
appli
compound
scientif
report
doi
mixtur
screen
specif
ligand
bind
assay
short
lc
gradient
b
first
min
kept
b
min
appli
proteinfre
control
prepar
use
buffer
substitut
np
underw
process
protein
incub
sampl
incub
sampl
correspond
control
prepar
analyz
triplic
eic
specif
compound
extract
use
masslynx
softwar
water
uk
base
accur
mass
measur
toler
da
ratio
peak
intens
protein
incub
sampl
vs
control
sampl
sn
calcul
compound
assess
bind
specif
individu
ligand
bind
assay
also
estim
fraction
specif
compound
associ
np
protein
bf
affin
k
given
incub
condit
use
method
report
previous
spr
analysi
spr
experi
perform
biacor
optic
biosensor
ge
healthcar
seri
sensor
chip
nh
edc
ethanolamin
hcl
well
sampl
vial
cap
obtain
biacor
hepe
buffer
ph
dmso
use
run
buffer
np
protein
gml
mm
sodium
acet
buffer
ph
inject
immobil
bind
cycl
compound
solut
inject
min
flow
rate
mlmin
dissoci
monitor
data
collect
biosensor
instrument
thermo
state
raw
data
process
remov
systemat
artifact
nonspecif
bind
signal
drift
bulk
refract
index
chang
solvent
correct
molecular
weight
adjust
appli
data
process
perform
use
biacor
evalu
softwar
fluorescencebas
thermal
shift
ft
assay
ft
assay
perform
protein
thermal
shift
dye
kit
tm
accord
user
protocol
thermo
fisher
usa
ebovnp
marvnp
protein
test
compound
dilut
correspond
incub
buffer
np
protein
mix
compound
ft
dye
total
volum
l
reaction
prepar
plate
seal
shaken
centrifug
rpm
min
thermal
scan
conduct
realtim
pcr
machin
lightcycl
roch
fluoresc
intens
continu
monitor
curv
fit
calcul
protein
melt
temperatur
tm
gener
data
report
carri
use
lightcycl
softwar
roch
approxim
g
purifi
np
protein
use
secmal
experi
select
compound
licoric
mix
either
np
protein
molar
excess
sampl
incub
overnight
light
scatter
data
collect
dawnheleo
ii
detector
wyatt
technolog
ca
usa
line
column
run
buffer
mm
tri
ph
mm
nacl
mm
dtt
raw
data
analyz
use
astra
softwar
wyatt
technolog
ca
usa
determin
weight
averag
molecular
mass
silico
dock
ebov
npligand
interact
coordin
structur
factor
ebov
np
deriv
rcsb
pdb
code
proteinligand
interact
analyz
use
discoveri
studio
neotrid
beij
china
ebov
np
structur
preprocess
ad
hydrogen
atom
dock
simul
optim
conform
ligandprotein
bind
state
retreat
spaciou
search
space
subsequ
analysi
interact
specif
compound
ebov
np
conduct
use
autodock
version
structur
cartoon
prepar
use
pymol
sequenc
align
perform
use
clustalw
graph
use
espript
rna
bind
assay
ebov
np
purifi
column
equilibr
highsalt
buffer
mm
trishcl
nacl
mm
dtt
ph
fraction
monom
collect
dilut
sevenfold
lowsalt
condit
obtain
np
oligom
free
rna
remov
rna
np
oligom
confirm
ratio
measur
fluoresc
polar
experi
establish
previous
describ
rna
cggacacacaaaaagaaa
correspond
posit
sens
ebov
leader
sequenc
label
terminu
carboxyfluoscein
purchas
takara
corpor
dalian
china
ebov
np
oligom
mix
rna
probe
dilut
fp
buffer
mm
mgcl
mm
trishcl
mm
nacl
mm
dtt
ph
final
concentr
nm
np
protein
serial
dilut
rna
bind
curv
analysi
competit
experi
ebov
np
monom
first
incub
differ
concentr
mixtur
dilut
sevenfold
lowsalt
condit
rna
probe
ad
nm
control
prepar
without
ad
monom
solut
fluoresc
anisotropi
read
flex
station
molecular
devic
report
anisotropi
signal
averag
standard
deviat
three
replic
experi
k
ic
determin
use
softwar
graphpad
prism
